Finance

Lists
IJF:FRA
ICON PLC
€135.75
-0.48%
(-0.65) 1D
Sep 10, 8:10:23 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IJF...
Open
€135.75
High
€135.75
Low
€135.75
Mkt. cap
12.65B
Avg. vol.
14.00
Volume
0.00
52-wk high
€170.30
52-wk low
€66.26
No. of employees
40K
Open
€135.75
High
€135.75
Low
€135.75
Mkt. cap
12.65B
Avg. vol.
14.00
Volume
0.00
52-wk high
€170.30
52-wk low
€66.26
No. of employees
40K
News stories
From web sources and news partners
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress. As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC
CEOBarry Balfe
Employees40.2K
Founded1990
Headquarters-
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.04B
2.19B
2.03B
2.06B
Cost of goods sold
1.49B
1.69B
1.55B
1.58B
Cost of revenue
1.49B
1.69B
1.55B
1.58B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
198.75M
-605.04M
202.30M
195.92M
Operating expense
297.24M
850.77M
292.63M
286.68M
Total operating expenses
1.78B
2.54B
1.85B
1.87B
Operating income
258.90M
-355.01M
187.00M
194.21M
Other non operating income
-
-9.38M
-
-
EBT including unusual items
38.10M
-142.45M
127.56M
92.20M
EBT excluding unusual items
210.42M
-409.19M
140.82M
148.58M
Income tax expense
35.75M
-17.01M
22.81M
19.62M
Effective tax rate
93.82%
11.94%
17.88%
21.27%
Other operating expenses
-
1.70B
-
-
Net income
2.36M
-125.44M
104.75M
72.58M
Net profit margin
0.12%
-5.73%
5.15%
3.52%
Earnings per share
3.31
2.52
2.50
2.56
Interest and investment income
1.76M
1.49M
1.82M
3.16M
Interest expense
-50.24M
-46.29M
-48.00M
-48.79M
Net interest expenses
-48.48M
-44.80M
-46.18M
-45.63M
Depreciation and amortization charges
98.50M
-292.17M
90.33M
90.77M
EBITDA
357.40M
-264.19M
277.33M
284.98M
Gain or loss from assets sale
-
-
-
32.95M
AI content may include mistakes. Learn more
Google apps